ALBUNORM

This brand name is authorized in Austria, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Lithuania, Malta, Poland, Romania, Singapore, Spain, Tunisia, UK.

Active ingredients

The drug ALBUNORM contains one active pharmaceutical ingredient (API):

1
UNII ZIF514RVZR - ALBUMIN HUMAN
 

Human albumin accounts quantitatively for more than half of the total protein in the plasma and represents about 10% of the protein synthesis activity of the liver. The most important physiological functions of albumin results from its contribution to oncotic pressure of the blood and transport function. Albumin stabilises circulating blood volume and is a carrier of hormones, enzymes, medicinal products and toxins.

 
Read more about Albumin

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 ALBUNORM Solution for infusion MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
B05AA01 Albumin B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products → B05AA Blood substitutes and plasma protein fractions
Discover more medicines within B05AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1347049, 1347050, 1347061, 1347072, 1347083, 1347094, 1347106, 1347117, 1347128, 1439962, 1439973, 1439984, 1439995, 1440098, 1440111
ES Centro de información online de medicamentos de la AEMPS 70738, 70739
FI Lääkealan turvallisuus- ja kehittämiskeskus 054343, 054376, 094554
FR Base de données publique des médicaments 66967127, 67960160, 69227858
GB Medicines & Healthcare Products Regulatory Agency 172269, 172271, 172273, 172275, 353788
HK Department of Health Drug Office 67180, 67181
HR Agencija za lijekove i medicinske proizvode HR-H-152403256, HR-H-587485812
IL מִשְׂרַד הַבְּרִיאוּת 7721, 7722, 7723
LT Valstybinė vaistų kontrolės tarnyba 1032078, 1032079, 1037663, 1037664, 1037665, 1037666, 1037667, 1037668, 1037669
MT Medicines Authority MA1219/00301, MA1219/00302, MA1219/00303, MA1219/00304, MA1219/00305
PL Rejestru Produktów Leczniczych 100215068, 100215111
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W65345001, W65345002, W65345003, W65345004, W65345005, W65346001, W65346002, W65346003, W65346004, W65347001, W65347002
SG Health Sciences Authority 15159P, 15160P, 15161P
TN Direction de la Pharmacie et du Médicament 10043011H

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.